Effect of angiotensin-converting enzyme inhibitors on renal function in patients with peripheral arterial disease

被引:0
|
作者
Hobbs, SD
Claridge, MW
Sam, RC
Thomas, ME
Wilmink, ABM
Adam, DJ
Bradbury, AW
机构
[1] Univ Birmingham, Dept Vasc Surg, Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[2] Univ Birmingham, Dept Nephrol, Birmingham Heartlands Hosp, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:510 / 510
页数:1
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme Inhibitors for Intermittent Claudication Associated With Peripheral Arterial Disease
    Hunter, Melissa R.
    Cahoon, William D., Jr.
    Lowe, Denise K.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1552 - 1557
  • [2] Angiotensin-Converting Enzyme Genotype and Peripheral Arterial Disease in Diabetic Patients
    Tseng, Chin-Hsiao
    Tseng, Farn-Hsuan
    Chong, Choon-Khim
    Tseng, Ching-Ping
    Cheng, Ju-Chien
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [3] Reduction of renal function by angiotensin-converting enzyme inhibitors: Effect of verapamil
    Bitar, R
    Martin, B
    LopezNovoa, JM
    MaciasNunez, JF
    NEPHRON, 1997, 75 (04): : 486 - 487
  • [4] Angiotensin-converting enzyme inhibitors in nondiabetic renal disease
    Colindres, RE
    Kshirsagar, AV
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (08) : 694 - 694
  • [5] Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease
    Jafar, TH
    Schmid, CH
    Levey, AS
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) : 298 - 299
  • [6] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND RENAL-FUNCTION
    MASON, NA
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (05): : 496 - 505
  • [7] Angiotensin-converting enzyme inhibitors in patients with vascular disease
    Pitt, Bertram
    EUROPEAN HEART JOURNAL, 2009, 30 (11) : 1307 - 1309
  • [8] Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or angiotensin-converting enzyme inhibitors
    Feringa, Harm H. H.
    Karagiannis, Stefanos E.
    Chonchol, Michel
    Vidakovic, Radosav
    Noordzij, Peter G.
    Elhendy, Abdou
    van Domburg, Ron T.
    Welten, Gijs
    Schouten, Olaf
    Bax, Jeroen J.
    Berl, Tomas
    Poldermans, Don
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1872 - 1879
  • [9] Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor?
    Al-Omran, M
    Lindsay, TF
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (02) : 189 - 193
  • [10] The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease
    Hirsch, AT
    Duprez, D
    VASCULAR MEDICINE, 2003, 8 (04) : 273 - 278